LRRK2 and Parkinson disease: Therefore, to determine whether the binding of p62 to pathogenic mutant LRRK2 is altered, we used WT LRRK2 and pathogenic LRRK2 variants (G2019S, R1441C, D1994A, and G2385R) found in familial PD patients.